Loader

Pathways

PathWhiz ID Pathway Meta Data

PW122450

Pw122450 View Pathway
physiological

Pathway

Homo sapiens

PW124347

Pw124347 View Pathway
disease

Pathway in cancer

Homo sapiens

PW000974

Pw000974 View Pathway
metabolic

PathWhiz Pt.2 - Video Learning Tutorials (Skeleton)

Homo sapiens

PW000954

Pw000954 View Pathway
metabolic

PathWhiz Pt.2 Learning Tutorials (Membrane)

Homo sapiens

PW000969

Pw000969 View Pathway
metabolic

PathWhiz Pt.2 Learning Tutorials (Red Membranes)

Homo sapiens

PW000945

Pw000945 View Pathway
metabolic

PathWhiz Pt.2 Learning Tutorials (Skeleton)

Homo sapiens

PW146056

Pw146056 View Pathway
drug action

Patiromer Drug Metabolism Action Pathway

Homo sapiens

PW126813

Pw126813 View Pathway
drug action

Paxlovid (Drug Action)

Homo sapiens

PW128514

Pw128514 View Pathway
drug action

Pazopanib Action Pathway

Homo sapiens
Pazopanib is an antineoplastic agent utilized for treating advanced renal cell cancer and advanced soft tissue sarcoma in patients who have undergone prior chemotherapy. This small molecule functions as an inhibitor of multiple protein tyrosine kinases, demonstrating potential antineoplastic activity. By targeting vascular endothelial growth factor receptors (VEGFR-1, -2, -3), platelet-derived growth factor receptors (PDGFR-alpha, PDGFR-beta), and c-kit, which are integral to the angiogenesis pathway, pazopanib hinders tumor blood vessel formation, ultimately impeding tumor survival and growth. Notably, it achieves steady-state concentrations conducive to maximal inhibition of VEGFR2 phosphorylation and exhibits anti-tumor effects, leading to a reduction in tumor blood flow, increased tumor apoptosis, inhibited growth, and hypoxia in cancer cells. Although absorption is slow and incomplete, with nonlinear tendencies over a dose range of 50-2000 mg, pazopanib's potency in targeting key receptors underscores its significance as a therapeutic option for patients with advanced renal cell cancer and advanced soft tissue sarcoma.

PW145718

Pw145718 View Pathway
drug action

Pazopanib Drug Metabolism Action Pathway

Homo sapiens